View of EVALUATION OF SAFETY AND EFFICACY OF DAPAGLIFLOZIN AS FIRST LINE MONOTHERAPY WITH METFORMIN IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS - A RANDOMIZED OPEN LABEL STUDY

Return to Article Details EVALUATION OF SAFETY AND EFFICACY OF DAPAGLIFLOZIN AS FIRST LINE MONOTHERAPY WITH METFORMIN IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS - A RANDOMIZED OPEN LABEL STUDY Download Download PDF